Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607 · cited 1×
“recognition by the macrophages are strongly correlated with the size as well as surface functionality of the particle (8).”
BackgroundAggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791 · cited 1×
“This phenomenon may be explained by the fact that smaller particles display a surface with a small radius of curvature preventing the efficient binding of opsonins (13).”
BackgroundYin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452 · cited 2×
“tion play a key role for a sustained PK and the NPs of 100– 200 nm in diameter may result in the best effects to escape from recognition by the reticuloendothelial system (17).”
BackgroundSelf-citationPoly-ϵ-caprolactone microspheres and nanospheres: an overview
Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R., & Trehan, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.044 · Cited by 1,100
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858 · cited 1×
“This also supports the claim by Desai (31).”
ResultThe physiology of the lymphatic system
Swartz, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00150-8 · Cited by 737
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Self-citationBrannon-Peppas, L. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00324-x · Cited by 528
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Dintaman, J. M., & Silverman, J. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1015000503629 · Cited by 426
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
Magnetic Nanoparticles and Their Applications in Medicine
Duguet, E., Vasseur, S., Mornet, S., & Devoisselle, J.-M. (2006) · Nanomedicine · doi:10.2217/17435889.1.2.157 · Cited by 399
Feng, S.-S., & Chien, S. (2003) · Chemical Engineering Science · doi:10.1016/s0009-2509(03)00234-3 · Cited by 364
Self-citationEvaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier
Wang, Q., Rager, J. D., Weinstein, K., Kardos, P. S., Dobson, G. L., Li, J., & Hidalgo, I. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.007 · Cited by 348
Oral exposure to polystyrene nanoparticles affects iron absorption
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.3 · Cited by 340
Mu, L., & Feng, S. S. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00025-1 · Cited by 328
Self-citationNano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier
Chang, J., Jallouli, Y., Kroubi, M., Yuan, X.-B., Feng, W., Kang, C.-S., Pu, P.-Y., & Betbeder, D. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.035 · Cited by 278
Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate
Florence, A. T., Hillery, A. M., Hussain, N., & Jani, P. U. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00059-h · Cited by 260
Brain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Mu, L., & Feng, S.-S. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003387.15428.42 · Cited by 250
Self-citationGeorgieva, J. V., Kalicharan, D., Couraud, P.-O., Romero, I. A., Weksler, B., Hoekstra, D., & Zuhorn, I. S. (2011) · Molecular Therapy · doi:10.1038/mt.2010.236 · Cited by 209
Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium
Foster, K. A., Yazdanian, M., & Audus, K. L. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775190 · Cited by 200
The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier
Cho, M. J., Thompson, D. P., Cramer, C. T., Vidmar, T. J., & Scieszka, J. F. (1989) · Pharmaceutical Research · doi:10.1023/a:1015807904558 · Cited by 194
Tan, J. S., Butterfield, D. E., Voycheck, C. L., Caldwell, K. D., & Li, J. T. (1993) · Biomaterials · doi:10.1016/0142-9612(93)90004-l · Cited by 191
Nanoparticle drug delivery system for restenosis
Labhasetwar, V., Song, C., & Levy, R. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00483-8 · Cited by 169
Freese, C., Uboldi, C., Gibson, M. I., Unger, R. E., Weksler, B. B., Romero, I. A., Couraud, P.-O., & Kirkpatrick, C. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-23 · Cited by 159
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration
Grabnar, P. A., Kristl, J., Kristl, A., & Vrečer, F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00076-5 · Cited by 157
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution
Vergoni, A. V., Tosi, G., Tacchi, R., Vandelli, M. A., Bertolini, A., & Costantino, L. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.02.005 · Cited by 150
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
Cavalli, R., Bargoni, A., Podio, V., Muntoni, E., Zara, G. P., & Gasco, M. R. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10368 · Cited by 133
Tosi, G., Vergoni, A. V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., Costantino, L., Forni, F., & Vandelli, M. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.008 · Cited by 123
Illum, L., & Davis, S. S. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720933 · Cited by 115
Kulkarni, S. A., & Feng, S.-S. (2011) · Nanomedicine · doi:10.2217/nnm.10.131 · Cited by 110
Self-citationHillery, A. M., & Florence, A. T. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04353-5 · Cited by 81 · cited 2×
“macrophages that reside mainly in the lungs, liver and spleen (28).”
BackgroundGao, H., Pang, Z., Fan, L., Hu, K., Wu, B., & Jiang, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.199 · Cited by 76
Jain, A., Chashoo, G., Singh, S. K., Saxena, A. K., & Jain, S. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.522257 · Cited by 62
Hombach, J., & Bernkop‐Schnürch, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.027 · Cited by 55
Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles
Dakwar, G. R., Hammad, I. A., Popov, M., Linder, C., Grinberg, S., Heldman, E., & Stepensky, D. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.042 · Cited by 54
Agarwal, A., Majumder, S., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2011) · Current Nanoscience · doi:10.2174/157341311794480291 · Cited by 43
Surface‐functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium
Sundaram, S., Roy, S. K., Ambati, B. K., & Kompella, U. B. (2009) · The FASEB Journal · doi:10.1096/fj.09-129825 · Cited by 43
Navarro, C., González‐Álvarez, I., González‐Álvarez, M., Manku, M. S., Merino, V., Casabó, V. G., & Bermejo, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.12.005 · Cited by 40
Characterization of the MDCK cell line for screening neurotoxicants.
Veronesi, B. (1996) · PubMed · Cited by 36
Cited by
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Bouwmeester, H., Hollman, P. C. H., & Peters, R. J. B. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b01090 · Cited by 1,180
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Impact of Microplastics and Nanoplastics on Human Health
Yee, M. S.-L., Hii, L.-W., Looi, C. K., Lim, W.-M., Wong, S.-F., Kok, Y.-Y., Tan, B.-K., Wong, C.-Y., & Leong, C.-O. (2021) · Nanomaterials · doi:10.3390/nano11020496 · Cited by 1,031
Presence of microplastics and nanoplastics in food, with particular focus on seafood
(CONTAM), E. P. O. C. I. T. F. C. (2016) · EFSA Journal · doi:10.2903/j.efsa.2016.4501 · Cited by 958
Metadata
- Authors
- Kulkarni, S. A., & Feng, S.-S.
- Venue
- Pharmaceutical Research
- Published
- 2013-01-12
- Volume
- 30
- Issue
- 10
- Pages
- 2512-2522
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2020747873
- Cited by
- 768
- References
- 44
- FWCI
- 14.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.